尚荣医疗收盘上涨1.08%，滚动市盈率141.78倍，总市值31.71亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Shangrong Medical, indicating a high PE ratio compared to industry averages [1][2] - As of June 16, the closing price of Shangrong Medical was 3.75 yuan, with a PE ratio of 141.78 and a total market capitalization of 3.171 billion yuan [1] - The average PE ratio for the medical device industry is 49.56, with a median of 36.18, positioning Shangrong Medical at the 111th rank within the industry [1][2] Group 2 - For Q1 2025, Shangrong Medical reported an operating income of 280 million yuan, a year-on-year increase of 30%, and a net profit of 13.9642 million yuan, reflecting a year-on-year growth of 0.58% [2] - The company's gross profit margin stands at 15.27% [2] - The company has a total of 58,323 shareholders, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] Group 3 - Shangrong Medical specializes in the production and sales of medical products, medical services, and health industry operations [1] - The company is recognized as one of the earliest to introduce clean technology into hospital operating rooms and has received multiple national honors for its innovative products [1] - Shangrong Medical holds over 180 patents, contributing to its ongoing development and innovation [1]